Warby Parker beats Q2 revenue estimates, announces CFO departure

Warby Parker

07/08/2025 11:57

Overview

Warby Parker Q2 rev grows 14% yr/yr, beating analyst expectations, per LSEG data

Adjusted EBITDA for Q2 beats consensus

Co raises full-year 2025 revenue outlook, and announces CFO Steve Miller to step down on Oct. 1

Outlook

Warby Parker raises 2025 revenue guidance to $880 mln-$888 mln

Company expects 2025 adjusted EBITDA of $98 mln-$101 mln

Warby Parker plans to open 45 new stores in 2025

Company projects 2025 adjusted EBITDA margin of 11.1%-11.4%

Result Drivers

AI INITIATIVES - Launch of AI-driven recommendation tool 'Advisor' showing strong early traction, per Co-CEO Dave Gilboa

STORE EXPANSION - Opened 11 new stores during Q2, ending with 298 stores, contributing to revenue growth

INVENTORY WRITE-DOWNS - Gross margin impacted by $2.5 mln inventory write-downs related to sunsetting Home-Try On program

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$214.48 mln
$213.10 mln (14 Analysts)
Q2 EPS
-$0.01
Q2 Net Income
-$1.75 mln
Q2 Adjusted EBITDA
Beat
$25 mln
$21.70 mln (13 Analysts)
Q2 Gross Margin
53.0%
Q2 Adjusted EBITDA Margin
11.7%
Q2 Gross Profit
$113.61 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Warby Parker Inc is $24.00, about 1.3% below its August 6 closing price of $24.30

The stock recently traded at 64 times the next 12-month earnings vs. a P/E of 47 three months ago

Press Release: ID:nBw4W8pP2a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)